ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,797,540 | -17.7% | 397,846 | -6.7% | 0.01% | -15.4% |
| Q2 2023 | $13,113,745 | +10.4% | 426,602 | +29.3% | 0.01% | 0.0% |
| Q1 2023 | $11,883,415 | -53.1% | 329,820 | -48.5% | 0.01% | -53.6% |
| Q4 2022 | $25,321,413 | -7.6% | 640,724 | -6.0% | 0.03% | -15.2% |
| Q3 2022 | $27,394,000 | +330.9% | 681,786 | +350.8% | 0.03% | +371.4% |
| Q2 2022 | $6,358,000 | +100.8% | 151,248 | +86.0% | 0.01% | +133.3% |
| Q1 2022 | $3,167,000 | +42.9% | 81,301 | +50.3% | 0.00% | +50.0% |
| Q2 2021 | $2,217,000 | – | 54,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |